Table 4 |
|||||
Distribution of study outcomes at baseline and endline, by treatment group and effect estimates of past-year intimate partner violence (Per protocol Analysis) (N = 934) | |||||
Treatment type | Baseline N (%) | Endline N (%) | Adjusted OR,^{q }95% CI | p-value | |
Physical and/or Sexual IPV | VSLA Only (Comparison)^{a} | 93 (22.1) | 78 (21.0) | -- | -- |
VSLA + GDG^{b} (Low adherence) | 64 (22.9) | 63 (24.6) | 1.19 (0.69, 2.05) | 0.64 | |
VSLA + GDG^{c} (High adherence) | 55 (23.5) | 37 (16.3) | 0.64 (0.35, 1.16)^{l} | 0.14 | |
Physical IPV | VSLA Only (Comparison)^{a} | 65 (15.4) | 55 (14.8) | -- | -- |
VSLA + GDG^{b} (Low adherence) | 44 (15.8) | 36 (14.1) | 0.93 (0.49, 1.77) | 0.82 | |
VSLA + GDG^{c} (High adherence) | 36 (15.4) | 17 (7.5) | 0.45 (0.21, 0.94)^{l} | 0.04 | |
Sexual IPV | VSLA Only (Comparison)^{a} | 44 (10.5) | 53 (14.3) | -- | -- |
VSLA + GDG^{b} (Low adherence) | 38 (13.6) | 41 (16.0) | 0.85 (0.44, 1.64) | 0.63 | |
VSLA + GDG^{c} (High adherence) | 33 (14.1) | 27 (11.9) | 0.54 (0.27, 1,10)^{l} | 0.11 | |
Economic abuse | VSLA Only (Comparison)^{d} | 113 (27.4) | 128 (34.6) | -- | -- |
VSLA + GDG^{e} (Low adherence) | 99 (36.3) | 56 (21.9) | 0.31 (0.18, 0.52) | <0.0001 | |
VSLA + GDG^{f} (High adherence) | 64 (28.1) | 48 (21.2) | 0.47 (0.27, 0.81)^{m} | 0.01 | |
Mean (SD) | Mean (SD) | Adjusted β (95% CI) | p-value | ||
Justification for wife beating | VSLA Only (Comparison)^{g} | 4.5 (4.3) | 4.0 (4.0) | ||
VLSA + GDG (Low adherence)^{h} | 5.2 (4.5) | 3.9 (4.3) | -0.19 (-1.13, 0.74)^{n} | 0.69 | |
VSLA + GDG^{i} (High adherence) | 4.5 (4.2) | 2.9 (3.6) | -1.14 (-2.01, -0.28) | 0.01 | |
Ability to refuse sex | VSLA Only (Comparison)^{j} | 5.7 (1.7) | 6.2 (1.5) | ||
VLSA + GDG (Low adherence)^{h} | 5.7 (1.8) | 6.3 (1.6) | 0.07 (-0.32, 0.46)^{o} | 0.72 | |
VSLA + GDG (High adherence)^{k} | 5.7 (1.7) | 6.4 (1.4) | 0.12 (-0.24, 0.48) | 0.50 |
^{a}Total n for VLSA only at baseline is 416; Total n for VLSA only at endline is 368.
^{b}Total n for VSLA + GDG low adherence at baseline is 275; Total n for VLSA + GDG low adherence at endline is 252.
^{c}Total n for VSLA + GDG high adherence at baseline is 232; Total n for VSLA + GDG high adherence at endline is 226.
^{d}Total n for VLSA only at baseline is 408; Total n for VLSA only at endline is 367.
^{e}Total n for VSLA + GDG low adherence at baseline is 270; Total n for VSLA + GDG low adherence at endline is 252.
^{f}Total n for VSLA + GDG high adherence at baseline is 227; Total n for VSLA + GDG high adherence at endline is 226.
^{g}Total n for VLSA only at baseline is 419; Total n for VLSA only at endline is 401.
^{h}Total n for VSLA + GDG low adherence at baseline is 278; Total n for VSLA + GDG low adherence at endline is 273.
^{i}Total n for VSLA + GDG high adherence at baseline is 233; Total n for VSLA + GDG high adherence at endline is 229.
^{j}Total n for VLSA only at baseline is 421; Total n for VLSA only at endline is 403.
^{k}Total n for VSLA + GDG high adherence at baseline is 234; Total n for VSLA + GDG high adherence at endline is 230.
^{l}Total observations in model is 1769/1868.
^{m}Total observations in model is 1750/1868.
^{n}Total observations in model is 1812/1868.
^{o}Total observations in model is 1818/1868.
^{p}Adjusted for categorical number of pregnancies and religion as they were statistically associated with adherence.
Gupta et al.
Gupta et al. BMC International Health and Human Rights 2013 13:46 doi:10.1186/1472-698X-13-46